Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Gastrointestinal Dysfunction in Parkinson's Disease.

Pfeiffer RF.

Curr Treat Options Neurol. 2018 Oct 25;20(12):54. doi: 10.1007/s11940-018-0539-9. Review.

PMID:
30361783
2.

ANNIVERSARY REVIEW: 50 years since the discovery of bromocriptine.

Michael Besser G, Pfeiffer RF, Thorner MO.

Eur J Endocrinol. 2018 Aug;179(2):R69-R75. doi: 10.1530/EJE-18-0378. Epub 2018 May 11. Review.

PMID:
29752299
3.

So long, and thanks for all the fish.

Wszolek ZK, Pfeiffer RF.

Parkinsonism Relat Disord. 2018 Jan;46:1. doi: 10.1016/j.parkreldis.2017.12.027. No abstract available.

PMID:
29295733
4.

Gastroenterology and Neurology.

Pfeiffer RF.

Continuum (Minneap Minn). 2017 Jun;23(3, Neurology of Systemic Disease):744-761. doi: 10.1212/CON.0000000000000484. Review.

PMID:
28570327
5.

Management of Autonomic Dysfunction in Parkinson's Disease.

Pfeiffer RF.

Semin Neurol. 2017 Apr;37(2):176-185. doi: 10.1055/s-0037-1601568. Epub 2017 May 16. Review.

PMID:
28511258
6.

Neuromuscular rate of force development deficit in Parkinson disease.

Hammond KG, Pfeiffer RF, LeDoux MS, Schilling BK.

Clin Biomech (Bristol, Avon). 2017 Jun;45:14-18. doi: 10.1016/j.clinbiomech.2017.04.003. Epub 2017 Apr 11.

PMID:
28432901
7.

Wilson Disease.

Pfeiffer RF.

Continuum (Minneap Minn). 2016 Aug;22(4 Movement Disorders):1246-61. doi: 10.1212/CON.0000000000000350. Review.

PMID:
27495207
8.

Non-motor symptoms in Parkinson's disease.

Pfeiffer RF.

Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S119-22. doi: 10.1016/j.parkreldis.2015.09.004. Epub 2015 Sep 3. Review.

PMID:
26372623
9.

Differentiating atypical parkinsonian syndromes--a way forward?

Pfeiffer RF.

Brain Behav. 2015 Jun;5(6):e00341. doi: 10.1002/brb3.341. No abstract available.

10.

Gastrointestinal dysfunction in Parkinson's disease.

Fasano A, Visanji NP, Liu LW, Lang AE, Pfeiffer RF.

Lancet Neurol. 2015 Jun;14(6):625-39. doi: 10.1016/S1474-4422(15)00007-1. Review.

PMID:
25987282
11.

Levodopa-induced lateral jaw deviation dystonia.

Pfeiffer RF, LeDoux MS.

Parkinsonism Relat Disord. 2015 Jul;21(7):808. doi: 10.1016/j.parkreldis.2015.02.012. Epub 2015 Apr 25. No abstract available.

PMID:
25956205
12.

Parkinson's disease and the gut: 'the wheel is come full circle'.

Pfeiffer RF.

J Parkinsons Dis. 2014;4(4):577-8. doi: 10.3233/JPD-149007. No abstract available.

PMID:
25468415
13.

Treatment of myoclonus-dystonia syndrome with tetrabenazine.

Luciano AY, Jinnah HA, Pfeiffer RF, Truong DD, Nance MA, LeDoux MS.

Parkinsonism Relat Disord. 2014 Dec;20(12):1423-6. doi: 10.1016/j.parkreldis.2014.09.029. Epub 2014 Oct 5.

14.

Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease.

Theuns J, Verstraeten A, Sleegers K, Wauters E, Gijselinck I, Smolders S, Crosiers D, Corsmit E, Elinck E, Sharma M, Krüger R, Lesage S, Brice A, Chung SJ, Kim MJ, Kim YJ, Ross OA, Wszolek ZK, Rogaeva E, Xi Z, Lang AE, Klein C, Weissbach A, Mellick GD, Silburn PA, Hadjigeorgiou GM, Dardiotis E, Hattori N, Ogaki K, Tan EK, Zhao Y, Aasly J, Valente EM, Petrucci S, Annesi G, Quattrone A, Ferrarese C, Brighina L, Deutschländer A, Puschmann A, Nilsson C, Garraux G, LeDoux MS, Pfeiffer RF, Boczarska-Jedynak M, Opala G, Maraganore DM, Engelborghs S, De Deyn PP, Cras P, Cruts M, Van Broeckhoven C; GEO-PD Consortium.

Neurology. 2014 Nov 18;83(21):1906-13. doi: 10.1212/WNL.0000000000001012. Epub 2014 Oct 17.

15.

A rare sequence variant in intron 1 of THAP1 is associated with primary dystonia.

Vemula SR, Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Truong DD, Blitzer A, Rudzińska M, Momčilović D, Jinnah HA, Frei K, Pfeiffer RF, LeDoux MS.

Mol Genet Genomic Med. 2014 May;2(3):261-72. doi: 10.1002/mgg3.67. Epub 2014 Feb 11.

16.

Gastrointestinal involvement in Parkinson's disease: the horse or the cart.

Pfeiffer RF.

Acta Physiol (Oxf). 2014 Jun;211(2):271-2. doi: 10.1111/apha.12300. No abstract available.

PMID:
24731168
17.

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

Parkinson Study Group QE3 Investigators, Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S, Leehey MA, Hermanowicz N, Niswonger S, Shill HA, Obradov S, Rajput A, Cowper M, Lessig S, Song D, Fontaine D, Zadikoff C, Williams K, Blindauer KA, Bergholte J, Propsom CS, Stacy MA, Field J, Mihaila D, Chilton M, Uc EY, Sieren J, Simon DK, Kraics L, Silver A, Boyd JT, Hamill RW, Ingvoldstad C, Young J, Thomas K, Kostyk SK, Wojcieszek J, Pfeiffer RF, Panisset M, Beland M, Reich SG, Cines M, Zappala N, Rivest J, Zweig R, Lumina LP, Hilliard CL, Grill S, Kellermann M, Tuite P, Rolandelli S, Kang UJ, Young J, Rao J, Cook MM, Severt L, Boyar K.

JAMA Neurol. 2014 May;71(5):543-52. doi: 10.1001/jamaneurol.2014.131.

PMID:
24664227
18.

Neurologic manifestations of malabsorption syndromes.

Pfeiffer RF.

Handb Clin Neurol. 2014;120:621-32. doi: 10.1016/B978-0-7020-4087-0.00042-5. Review.

PMID:
24365342
19.

Cognitive and motor function in long-duration PARKIN-associated Parkinson disease.

Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, Ruiz D, Louis ED, Comella CL, Nance MA, Bressman SB, Scott WK, Tanner CM, Mickel SF, Waters CH, Fahn S, Cote LJ, Frucht SJ, Ford B, Rezak M, Novak KE, Friedman JH, Pfeiffer RF, Marsh L, Hiner B, Payami H, Molho E, Factor SA, Nutt JG, Serrano C, Arroyo M, Ottman R, Pauciulo MW, Nichols WC, Clark LN, Marder KS.

JAMA Neurol. 2014 Jan;71(1):62-7. doi: 10.1001/jamaneurol.2013.4498.

20.

Is α-synuclein rising to the surface as a diagnostic biomarker for Parkinson disease?

Cheshire WP, Pfeiffer RF.

Neurology. 2013 Oct 29;81(18):1568-9. doi: 10.1212/WNL.0b013e3182a9f5ab. Epub 2013 Oct 2.

PMID:
24089391
21.

Autonomic dysfunction in Parkinson's disease.

Pfeiffer RF.

Expert Rev Neurother. 2012 Jun;12(6):697-706. doi: 10.1586/ern.12.17. Review.

PMID:
22650172
22.

Alterations in glutathione S-transferase pi expression following exposure to MPP+ -induced oxidative stress in the blood of Parkinson's disease patients.

Korff A, Pfeiffer B, Smeyne M, Kocak M, Pfeiffer RF, Smeyne RJ.

Parkinsonism Relat Disord. 2011 Dec;17(10):765-8. doi: 10.1016/j.parkreldis.2011.06.026. Epub 2011 Aug 12.

23.

A family with Parkinsonism, essential tremor, restless legs syndrome, and depression.

Puschmann A, Pfeiffer RF, Stoessl AJ, Kuriakose R, Lash JL, Searcy JA, Strongosky AJ, Vilariño-Güell C, Farrer MJ, Ross OA, Dickson DW, Wszolek ZK.

Neurology. 2011 May 10;76(19):1623-30. doi: 10.1212/WNL.0b013e318219fb42.

24.

Wilson's disease.

Pfeiffer RF.

Handb Clin Neurol. 2011;100:681-709. doi: 10.1016/B978-0-444-52014-2.00049-5. Review.

PMID:
21496616
25.

Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6.

Xiao J, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, LeDoux MS.

Hum Genet. 2010 Apr;127(4):470. No abstract available.

PMID:
21488298
26.

Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6.

Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, LeDoux MS.

Hum Genet. 2010 Apr;127(4):470. No abstract available.

PMID:
21488297
27.

Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6.

Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, LeDoux MS.

Hum Genet. 2010 Apr;127(4):469-70. No abstract available.

PMID:
21488296
28.

Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6.

Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, LeDoux MS.

Hum Genet. 2010 Apr;127(4):469. No abstract available.

PMID:
21488277
29.

Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6.

Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, LeDoux MS.

Hum Genet. 2010 Apr;127(4):470. No abstract available.

PMID:
21488252
30.

The c.-237_236GA>TT THAP1 sequence variant does not increase risk for primary dystonia.

Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Simon DK, Tarsy D, Hedera P, Truong DD, Frei KP, Blitzer A, Rudzińska M, Pfeiffer RF, Le C, LeDoux MS.

Mov Disord. 2011 Feb 15;26(3):549-52. doi: 10.1002/mds.23551. Epub 2011 Mar 2. Erratum in: Mov Disord. 2012 Mar;27(3):465.

31.

Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study.

Caccappolo E, Alcalay RN, Mejia-Santana H, Tang MX, Rakitin B, Rosado L, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, Tanner CM, Mickel SF, Andrews HF, Waters C, Fahn S, Cote LJ, Frucht S, Ford B, Rezak M, Novak K, Friedman JH, Pfeiffer RF, Marsh L, Hiner B, Siderowf AD, Ross BM, Verbitsky M, Kisselev S, Ottman R, Clark LN, Marder KS.

J Int Neuropsychol Soc. 2011 Jan;17(1):91-100. doi: 10.1017/S1355617710001190. Epub 2010 Nov 24.

32.

Effects of moderate-volume, high-load lower-body resistance training on strength and function in persons with Parkinson's disease: a pilot study.

Schilling BK, Pfeiffer RF, Ledoux MS, Karlage RE, Bloomer RJ, Falvo MJ.

Parkinsons Dis. 2010 Mar 16;2010:824734. doi: 10.4061/2010/824734.

33.

Gastrointestinal dysfunction in Parkinson's disease.

Pfeiffer RF.

Parkinsonism Relat Disord. 2011 Jan;17(1):10-5. doi: 10.1016/j.parkreldis.2010.08.003. Epub 2010 Sep 15. Review.

PMID:
20829091
34.

Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.

Marder KS, Tang MX, Mejia-Santana H, Rosado L, Louis ED, Comella CL, Colcher A, Siderowf AD, Jennings D, Nance MA, Bressman S, Scott WK, Tanner CM, Mickel SF, Andrews HF, Waters C, Fahn S, Ross BM, Cote LJ, Frucht S, Ford B, Alcalay RN, Rezak M, Novak K, Friedman JH, Pfeiffer RF, Marsh L, Hiner B, Neils GD, Verbitsky M, Kisselev S, Caccappolo E, Ottman R, Clark LN.

Arch Neurol. 2010 Jun;67(6):731-8. doi: 10.1001/archneurol.2010.95.

35.

Parkinson disease: calcium channel blockers and Parkinson disease.

Pfeiffer RF.

Nat Rev Neurol. 2010 Apr;6(4):188-9. doi: 10.1038/nrneurol.2010.31. No abstract available.

PMID:
20379202
36.

Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease.

Simon DK, Pankratz N, Kissell DK, Pauciulo MW, Halter CA, Rudolph A, Pfeiffer RF, Nichols WC, Foroud T; Parkinson Study Group-PROGENI Investigators.

BMC Med Genet. 2010 Apr 1;11:53. doi: 10.1186/1471-2350-11-53.

37.

Gastrointestinal, urological, and sexual dysfunction in Parkinson's disease.

Pfeiffer RF.

Mov Disord. 2010;25 Suppl 1:S94-7. doi: 10.1002/mds.22715.

PMID:
20187255
38.

Annual report.

Pfeiffer RF, Wszolek ZK.

Parkinsonism Relat Disord. 2010 Jan;16(1):1. doi: 10.1016/j.parkreldis.2009.12.005. No abstract available.

PMID:
20123568
39.

Novel THAP1 sequence variants in primary dystonia.

Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Simon DK, Tarsy D, Hedera P, Truong DD, Frei KP, Dev Batish S, Blitzer A, Pfeiffer RF, Gong S, LeDoux MS.

Neurology. 2010 Jan 19;74(3):229-38. doi: 10.1212/WNL.0b013e3181ca00ca.

40.

Neurologic presentations of gastrointestinal disease.

Pfeiffer RF.

Neurol Clin. 2010 Feb;28(1):75-87. doi: 10.1016/j.ncl.2009.09.007.

PMID:
19932377
41.

Neuroinflammation and Parkinson disease: the silent battleground.

Pfeiffer RF.

Neurology. 2009 Nov 3;73(18):1434-5. doi: 10.1212/WNL.0b013e3181c2f07d. Epub 2009 Oct 7. No abstract available.

PMID:
19812378
42.

Parkinson disease. Nonmotor symptoms in Parkinson disease: the PRIAMO study.

Pfeiffer RF.

Nat Rev Neurol. 2009 Oct;5(10):531-2. doi: 10.1038/nrneurol.2009.156.

PMID:
19794513
43.

Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations.

Pankratz N, Kissell DK, Pauciulo MW, Halter CA, Rudolph A, Pfeiffer RF, Marder KS, Foroud T, Nichols WC; Parkinson Study Group-PROGENI Investigators.

Neurology. 2009 Jul 28;73(4):279-86. doi: 10.1212/WNL.0b013e3181af7a33.

44.

Impaired leg extensor strength in individuals with Parkinson disease and relatedness to functional mobility.

Schilling BK, Karlage RE, LeDoux MS, Pfeiffer RF, Weiss LW, Falvo MJ.

Parkinsonism Relat Disord. 2009 Dec;15(10):776-80. doi: 10.1016/j.parkreldis.2009.06.002. Epub 2009 Jun 26.

PMID:
19560392
45.

Alpha-synuclein and familial Parkinson's disease.

Pankratz N, Nichols WC, Elsaesser VE, Pauciulo MW, Marek DK, Halter CA, Wojcieszek J, Rudolph A, Pfeiffer RF, Foroud T; Parkinson Study Group - PROGENI Investigators.

Mov Disord. 2009 Jun 15;24(8):1125-31. doi: 10.1002/mds.22524.

46.

High-throughput mutational analysis of TOR1A in primary dystonia.

Xiao J, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, Zhao Y, LeDoux MS.

BMC Med Genet. 2009 Mar 11;10:24. doi: 10.1186/1471-2350-10-24.

47.

Variation in GIGYF2 is not associated with Parkinson disease.

Nichols WC, Kissell DK, Pankratz N, Pauciulo MW, Elsaesser VE, Clark KA, Halter CA, Rudolph A, Wojcieszek J, Pfeiffer RF, Foroud T; Parkinson Study Group-PROGENI Investigators.

Neurology. 2009 Jun 2;72(22):1886-92. doi: 10.1212/01.wnl.0000346517.98982.1b. Epub 2009 Mar 11.

48.

Genetic factors influencing age at onset in LRRK2-linked Parkinson disease.

Golub Y, Berg D, Calne DB, Pfeiffer RF, Uitti RJ, Stoessl AJ, Wszolek ZK, Farrer MJ, Mueller JC, Gasser T, Fuchs J.

Parkinsonism Relat Disord. 2009 Aug;15(7):539-41. doi: 10.1016/j.parkreldis.2008.10.008. Epub 2008 Nov 28.

PMID:
19041274
49.

Non-motor parkinsonism.

Pfeiffer RF.

Parkinsonism Relat Disord. 2007;13 Suppl 3:S211-20. doi: 10.1016/S1353-8020(08)70004-X. Review.

PMID:
18267238
50.

Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset.

Nichols WC, Pankratz N, Marek DK, Pauciulo MW, Elsaesser VE, Halter CA, Rudolph A, Wojcieszek J, Pfeiffer RF, Foroud T; Parkinson Study Group-PROGENI Investigators.

Neurology. 2009 Jan 27;72(4):310-6. doi: 10.1212/01.wnl.0000327823.81237.d1. Epub 2008 Nov 5.

Supplemental Content

Loading ...
Support Center